Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Stopped Withdrawn
Conditions
- Fatigue
- Malignant Ovarian Mixed Epithelial Tumor
- Neuropathy
- Neurotoxicity Syndrome
- Ovarian Brenner Tumor
- Ovarian Clear Cell Cystadenocarcinoma
- Ovarian Endometrioid Adenocarcinoma
- Ovarian Mucinous Cystadenocarcinoma
- Ovarian Serous Cystadenocarcinoma
- Pain
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
Interventions
- DIETARY_SUPPLEMENT: Acetyl-L-Carnitine Hydrochloride
- OTHER: Placebo
- OTHER: Questionnaire Administration
- OTHER: Quality-of-Life Assessment
Sponsor
Gynecologic Oncology Group
Collaborators